Literature DB >> 23125224

Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients.

Jinyun Chen1, Mala Pande, Yu-Jing Huang, Chongjuan Wei, Christopher I Amos, Bente A Talseth-Palmer, Cliff J Meldrum, Wei V Chen, Ivan P Gorlov, Patrick M Lynch, Rodney J Scott, Marsha L Frazier.   

Abstract

Heterogeneity in age of onset of colorectal cancer in individuals with mutations in DNA mismatch repair genes (Lynch syndrome) suggests the influence of other lifestyle and genetic modifiers. We hypothesized that genes regulating the cell cycle influence the observed heterogeneity as cell cycle-related genes respond to DNA damage by arresting the cell cycle to provide time for repair and induce transcription of genes that facilitate repair. We examined the association of 1456 single nucleotide polymorphisms (SNPs) in 128 cell cycle-related genes and 31 DNA repair-related genes in 485 non-Hispanic white participants with Lynch syndrome to determine whether there are SNPs associated with age of onset of colorectal cancer. Genotyping was performed on an Illumina GoldenGate platform, and data were analyzed using Kaplan-Meier survival analysis, Cox regression analysis and classification and regression tree (CART) methods. Ten SNPs were independently significant in a multivariable Cox proportional hazards regression model after correcting for multiple comparisons (P < 5 × 10(-4)). Furthermore, risk modeling using CART analysis defined combinations of genotypes for these SNPs with which subjects could be classified into low-risk, moderate-risk and high-risk groups that had median ages of colorectal cancer onset of 63, 50 and 42 years, respectively. The age-associated risk of colorectal cancer in the high-risk group was more than four times the risk in the low-risk group (hazard ratio = 4.67, 95% CI = 3.16-6.92). The additional genetic markers identified may help in refining risk groups for more tailored screening and follow-up of non-Hispanic white patients with Lynch syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125224      PMCID: PMC3564440          DOI: 10.1093/carcin/bgs344

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  71 in total

1.  Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer.

Authors:  Alan M Pittman; Emily Webb; Luis Carvajal-Carmona; Kimberley Howarth; Maria Chiara Di Bernardo; Peter Broderick; Sarah Spain; Axel Walther; Amy Price; Kate Sullivan; Philip Twiss; Sarah Fielding; Andrew Rowan; Emma Jaeger; Jayaram Vijayakrishnan; Ian Chandler; Steven Penegar; Mobshra Qureshi; Steven Lubbe; Enric Domingo; Zoe Kemp; Ella Barclay; Wendy Wood; Lynn Martin; Maggie Gorman; Huw Thomas; Julian Peto; Timothy Bishop; Richard Gray; Eamonn R Maher; Anneke Lucassen; David Kerr; Gareth R Evans; Tom van Wezel; Hans Morreau; Juul T Wijnen; John L Hopper; Melissa C Southey; Graham G Giles; Gianluca Severi; Sergi Castellví-Bel; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Asta Försti; Kari Hemminki; Pavel Vodicka; Alessio Naccarati; Lara Lipton; Judy W C Ho; K K Cheng; Pak C Sham; J Luk; Jose A G Agúndez; Jose M Ladero; Miguel de la Hoya; Trinidad Caldés; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri A Aaltonen; Jean-Baptiste Cazier; Ian P M Tomlinson; Richard S Houlston
Journal:  Hum Mol Genet       Date:  2008-08-27       Impact factor: 6.150

2.  Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center.

Authors:  Mala Pande; Patrick M Lynch; John L Hopper; Mark A Jenkins; Steve Gallinger; Robert W Haile; Loic LeMarchand; Noralane M Lindor; Peter T Campbell; Polly A Newcomb; John D Potter; John A Baron; Marsha L Frazier; Christopher I Amos
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status.

Authors:  Peter T Campbell; Elizabeth T Jacobs; Cornelia M Ulrich; Jane C Figueiredo; Jenny N Poynter; John R McLaughlin; Robert W Haile; Eric J Jacobs; Polly A Newcomb; John D Potter; Loïc Le Marchand; Roger C Green; Patrick Parfrey; H Banfield Younghusband; Michelle Cotterchio; Steven Gallinger; Mark A Jenkins; John L Hopper; John A Baron; Stephen N Thibodeau; Noralane M Lindor; Paul J Limburg; María Elena Martínez
Journal:  J Natl Cancer Inst       Date:  2010-03-05       Impact factor: 13.506

4.  Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

Authors:  Marietta E Kovacs; Janos Papp; Zoltan Szentirmay; Szabolcs Otto; Edith Olah
Journal:  Hum Mutat       Date:  2009-02       Impact factor: 4.878

5.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

Authors:  Marjolijn J L Ligtenberg; Roland P Kuiper; Tsun Leung Chan; Monique Goossens; Konnie M Hebeda; Marsha Voorendt; Tracy Y H Lee; Danielle Bodmer; Eveline Hoenselaar; Sandra J B Hendriks-Cornelissen; Wai Yin Tsui; Chi Kwan Kong; Han G Brunner; Ad Geurts van Kessel; Siu Tsan Yuen; J Han J M van Krieken; Suet Yi Leung; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

6.  An integrative scoring system for ranking SNPs by their potential deleterious effects.

Authors:  Phil Hyoun Lee; Hagit Shatkay
Journal:  Bioinformatics       Date:  2009-02-19       Impact factor: 6.937

Review 7.  New insights into the aetiology of colorectal cancer from genome-wide association studies.

Authors:  Albert Tenesa; Malcolm G Dunlop
Journal:  Nat Rev Genet       Date:  2009-06       Impact factor: 53.242

8.  Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer.

Authors:  Richard S Houlston; Emily Webb; Peter Broderick; Alan M Pittman; Maria Chiara Di Bernardo; Steven Lubbe; Ian Chandler; Jayaram Vijayakrishnan; Kate Sullivan; Steven Penegar; Luis Carvajal-Carmona; Kimberley Howarth; Emma Jaeger; Sarah L Spain; Axel Walther; Ella Barclay; Lynn Martin; Maggie Gorman; Enric Domingo; Ana S Teixeira; David Kerr; Jean-Baptiste Cazier; Iina Niittymäki; Sari Tuupanen; Auli Karhu; Lauri A Aaltonen; Ian P M Tomlinson; Susan M Farrington; Albert Tenesa; James G D Prendergast; Rebecca A Barnetson; Roseanne Cetnarskyj; Mary E Porteous; Paul D P Pharoah; Thibaud Koessler; Jochen Hampe; Stephan Buch; Clemens Schafmayer; Jurgen Tepel; Stefan Schreiber; Henry Völzke; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner; Brent W Zanke; Alexandre Montpetit; Thomas J Hudson; Steven Gallinger; Harry Campbell; Malcolm G Dunlop
Journal:  Nat Genet       Date:  2008-11-16       Impact factor: 38.330

9.  Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21.

Authors:  Karen Curtin; Wei-Yu Lin; Rina George; Mark Katory; Jennifer Shorto; Lisa A Cannon-Albright; D Timothy Bishop; Angela Cox; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01-20       Impact factor: 4.254

10.  ENCODE whole-genome data in the UCSC Genome Browser.

Authors:  Kate R Rosenbloom; Timothy R Dreszer; Michael Pheasant; Galt P Barber; Laurence R Meyer; Andy Pohl; Brian J Raney; Ting Wang; Angie S Hinrichs; Ann S Zweig; Pauline A Fujita; Katrina Learned; Brooke Rhead; Kayla E Smith; Robert M Kuhn; Donna Karolchik; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2009-11-17       Impact factor: 16.971

View more
  6 in total

Review 1.  History, genetics, and strategies for cancer prevention in Lynch syndrome.

Authors:  Fay Kastrinos; Elena M Stoffel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-23       Impact factor: 11.382

2.  Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene.

Authors:  Aung Ko Win; Jeanette C Reece; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Sean P Cleary; Hyeja Kim; Michelle Cotterchio; James G Dowty; Robert J MacInnis; Katherine M Tucker; Ingrid M Winship; Finlay A Macrae; Terrilea Burnett; Loïc Le Marchand; Graham Casey; Robert W Haile; Polly A Newcomb; Stephen N Thibodeau; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

3.  The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis.

Authors:  Neil Donald; Salim Malik; Joshua L McGuire; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

4.  Genetic anticipation in Swedish Lynch syndrome families.

Authors:  Jenny von Salomé; Philip S Boonstra; Masoud Karimi; Gustav Silander; Marie Stenmark-Askmalm; Samuel Gebre-Medhin; Christos Aravidis; Mef Nilbert; Annika Lindblom; Kristina Lagerstedt-Robinson
Journal:  PLoS Genet       Date:  2017-10-31       Impact factor: 5.917

5.  Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.

Authors: 
Journal:  Lancet Oncol       Date:  2021-06-07       Impact factor: 54.433

6.  A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.

Authors:  Jeroen A C M Goos; Veerle M H Coupé; Mark A van de Wiel; Begoña Diosdado; Pien M Delis-Van Diemen; Annemieke C Hiemstra; Erienne M V de Cuba; Jeroen A M Beliën; C Willemien Menke-van der Houven van Oordt; Albert A Geldof; Gerrit A Meijer; Otto S Hoekstra; Remond J A Fijneman
Journal:  Oncotarget       Date:  2016-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.